1. Home
  2. AVXL vs GOGO Comparison

AVXL vs GOGO Comparison

Compare AVXL & GOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • GOGO
  • Stock Information
  • Founded
  • AVXL 2004
  • GOGO 1991
  • Country
  • AVXL United States
  • GOGO United States
  • Employees
  • AVXL N/A
  • GOGO N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • GOGO Telecommunications Equipment
  • Sector
  • AVXL Health Care
  • GOGO Consumer Discretionary
  • Exchange
  • AVXL Nasdaq
  • GOGO Nasdaq
  • Market Cap
  • AVXL 876.0M
  • GOGO 965.2M
  • IPO Year
  • AVXL N/A
  • GOGO 2013
  • Fundamental
  • Price
  • AVXL $9.21
  • GOGO $7.85
  • Analyst Decision
  • AVXL Strong Buy
  • GOGO Buy
  • Analyst Count
  • AVXL 2
  • GOGO 3
  • Target Price
  • AVXL $44.00
  • GOGO $12.17
  • AVG Volume (30 Days)
  • AVXL 2.9M
  • GOGO 1.1M
  • Earning Date
  • AVXL 02-05-2025
  • GOGO 02-26-2025
  • Dividend Yield
  • AVXL N/A
  • GOGO N/A
  • EPS Growth
  • AVXL N/A
  • GOGO N/A
  • EPS
  • AVXL N/A
  • GOGO 0.43
  • Revenue
  • AVXL N/A
  • GOGO $404,720,000.00
  • Revenue This Year
  • AVXL N/A
  • GOGO $3.79
  • Revenue Next Year
  • AVXL N/A
  • GOGO $10.69
  • P/E Ratio
  • AVXL N/A
  • GOGO $18.28
  • Revenue Growth
  • AVXL N/A
  • GOGO N/A
  • 52 Week Low
  • AVXL $3.25
  • GOGO $6.17
  • 52 Week High
  • AVXL $14.44
  • GOGO $11.17
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 43.28
  • GOGO 53.50
  • Support Level
  • AVXL $10.04
  • GOGO $6.85
  • Resistance Level
  • AVXL $11.68
  • GOGO $7.99
  • Average True Range (ATR)
  • AVXL 1.22
  • GOGO 0.35
  • MACD
  • AVXL -0.35
  • GOGO 0.00
  • Stochastic Oscillator
  • AVXL 4.52
  • GOGO 61.35

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Business Aviation. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services. and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.

Share on Social Networks: